To the Editor: As the information load of modern psychopharmacology continues to expand, and expert teachers are torn away from the lecture room by multiple competing demands (1), the need for development of comprehensive psychopharmacology curricula has mushroomed (1). To help meet this need, the American College of Neuropsychopharmacology (ACNP), American Society for Clinical Psychopharmacology (ASCP), and American Association of Directors of Psychiatric Residency Training (AADPRT), have initiated a series of multi-modal, disease-based model psychopharmacology curricula or subcurricula (2, 3). Recently, ASCP’s Residents and Fellows Committee (RFC) has developed novel, multi-modal psychopharmacology curricula in major depression and bipolar disorder to support psychopharmacology education (4, 5). As part of our efforts to disseminate the model curricula, we sought feedback from psychiatry residency training directors about their interest in implementing such curricula and potential barriers to their use.